Fortress Biotech, Inc.
FBIO
$1.64
-$0.02-1.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.77M | -12.87M | -10.95M | -15.42M | -9.28M |
| Total Depreciation and Amortization | 1.13M | 957.00K | 1.19M | 1.19M | 1.19M |
| Total Amortization of Deferred Charges | 300.00K | 389.00K | 756.00K | 609.00K | 508.00K |
| Total Other Non-Cash Items | -1.83M | -3.67M | -9.65M | -17.44M | -9.20M |
| Change in Net Operating Assets | -5.73M | -4.87M | -3.19M | 5.67M | -18.15M |
| Cash from Operations | -12.91M | -20.06M | -21.84M | -25.39M | -34.94M |
| Capital Expenditure | -- | -- | -- | -- | -28.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.00M | -- | -- | -- | -35.00K |
| Cash from Investing | -15.00M | -- | -- | -- | -63.00K |
| Total Debt Issued | 5.00M | 33.67M | 5.00M | -- | 14.53M |
| Total Debt Repaid | -625.00K | -625.00K | -- | -- | 91.00K |
| Issuance of Common Stock | 674.00K | 8.05M | -- | 15.77M | 9.29M |
| Repurchase of Common Stock | -- | -- | -2.27M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -400.00K |
| Total Dividends Paid | 0.00 | 0.00 | -2.01M | -2.01M | -2.01M |
| Other Financing Activities | 20.76M | -38.38M | 13.55M | 14.09M | 22.11M |
| Cash from Financing | 25.81M | 2.71M | 14.27M | 27.86M | 43.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.10M | -17.35M | -7.57M | 2.47M | 8.62M |